The advanced lung cancer inflammation index (ALI), as a newly reported inflammation-based prognostic score, is based on body mass index (BMI), serum albumin (ALB), and neutrophil to lymphocyte ratio (NLR). This evidence concerns the gene ALB and lung carcinoma.